Peer-influenced content. Sources you trust. No registration required. This is HCN.
Neurology Learning Network
In the latest findings on gantenerumab, while the anticipated cognitive benefits in Alzheimer’s patients were not realized, the drug demonstrated significant impacts on biomarkers, including amyloid plaque reduction and alterations in CSF phosphorylated tau and Aβ42 levels.
Geriatrics April 2nd 2024
Cleveland Clinic Journal of Medicine
Psychogenic nonepileptic seizures (PNES) necessitate a multidisciplinary approach, combining neurologic evaluation with psychological insights to ensure accurate diagnosis and effective patient care. Early and accurate diagnosis is critical to avoid unnecessary treatments and to engage patients in appropriate psychological therapies.
Neurology April 2nd 2024
MDLinx
This study emphasizes the critical need for integrated nutritional assessments and interventions in patients with Alzheimer’s, highlighting how malnutrition and the disease exacerbate each other, impacting patient care and outcomes.
The New England Journal of Medicine
A 2019 trial report from NEJM offered a comparative analysis of levetiracetam, fosphenytoin, and valproate in managing benzodiazepine-resistant convulsive status epilepticus, providing essential insights into their efficacy and safety, aiding clinicians in informed decision-making.
This study underscores the complexity of prescribing antiseizure medications during pregnancy, revealing that while topiramate and lamotrigine show no significant increase in autism spectrum disorder risk post-adjustment, valproate exposure remains a concern due to its association with a higher ASD incidence.
FAP News Today
In the realm of rare diseases, early diagnosis is a critical challenge. Machine learning is emerging as a pivotal tool in identifying familial amyloid polyneuropathy (FAP) patients, promising a new era of precision in genetic testing and timely treatment initiation.
Cardiology March 25th 2024